Proteome Sciences

PRM · AIM · Health Care · mcap £5.3m · 1.4p

Beta Briefing, track record and bull & bear case are not ready for Proteome Sciences yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 37 companies are already wired into a briefing: browse them.

Vulpes Investment Management Pte Ltd 4 Feb · 1 notice

22.8% → 24.2%

share price at the notices 1.8p · now 1.4p 4 Feb 2026

Spreadex LTD 3 Feb · 1 notice

1.6% → 1.5%

share price at the notices 1.8p · now 1.4p 3 Feb 2026

Directors

No open-market share purchases by directors in 12 months.

other Proteome Sciences plc announced that Dr. Ian Pike will step down as Chief Scientific Officer effective May 31, 2026, transitioning to a Non-Executive Director role on the same date. He has committed to providing consulta 1 Jun 2026

award Proteome Sciences plc has appointed Helen Spice FCA as an independent non-executive director, effective immediately, bringing extensive strategic, financial, and accounting experience from her career at KPMG and her non- 16 Sep 2026

Company filings. Not investment advice.